Bristol-Myers Squibb Balance Sheet Statement

Assets, liabilities, and shareholders' equity

Bristol-Myers Squibb holds $86.5B in total assets. Shareholders' equity is $20.1B against $47.0B in total debt. Cash and equivalents total $9.6B. The current ratio is 1.42 and debt-to-equity is 2.34. Based on the Q1 2026 filing.